Acta Med. 2019, 62: 156-160
https://doi.org/10.14712/18059694.2020.5
Primary Hyperparathyroidism Manifesting with Severe Hypercalcemia in a Nonagenarian Man: Pitfall of Common Imaging Techniques, Localization by 18F-Choline Positron Emission Tomography/Computed Tomography and Successful Management with Calcimimetics
References
1. MW, Ituarte PH, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab 2013; 98: 1122–9.
<https://doi.org/10.1210/jc.2012-4022>
<PubMed>
2. A, Borg B, Xie R, et al. Why Is Hyperparathyroidism Underdiagnosed and Undertreated in Older Adults? Clin Med Insights Endocrinol Diabetes 2018; 11: 1179551418815916.
<https://doi.org/10.1177/1179551418815916>
<PubMed>
3. KL Primary Hyperparathyroidism. N Engl J Med 2018; 379: 1050–59.
<https://doi.org/10.1056/NEJMcp1714213>
4. M, Hehenwarter L, Paymani Z, et al. F-Fluorocholine PET/ CT in the assessment of primary hyperparathyroidism compared with (99m)Tc-MIBI or (99m)Tc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients. Eur J Nucl Med Mol Imaging 2018; 45: 1762–71.
<https://doi.org/10.1007/s00259-018-3980-9>
<PubMed>
5. F, Cetani F, Repaci A, et al. Clinical presentation and management of patients with primary hyperparathyroidism in Italy. J Endocrinol Invest 2018; 41: 1339–48.
<https://doi.org/10.1007/s40618-018-0879-z>
6. G, Felber R, Schwarz C, et al. Hypercalcemia in the ED: prevalence, etiology, and outcome. Am J Emerg Med 2013; 31: 657–60.
<https://doi.org/10.1016/j.ajem.2012.11.010>
7. JD, Levine SN. Hypercalcemia in the Intensive Care Unit: A review of pathophysiology, diagnosis, and modern therapy. J Intensive Care Med 2015; 30: 235–52.
<https://doi.org/10.1177/0885066613507530>
8. N, Tublin ME, Ogilvie JB. AJR Am J Roentgenol 2007; 188: 1706–15.
<https://doi.org/10.2214/AJR.06.0938>
9. A, Bilezikian J, Bone H, et al. Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery. Eur J Endocrinol 2015; 172: 527–35.
<https://doi.org/10.1530/EJE-14-0877>
<PubMed>
